<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Med Sci</journal-id><journal-id journal-id-type="publisher-id">IJMS</journal-id><journal-title-group><journal-title>Iranian Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">0253-0716</issn><issn pub-type="epub">1735-3688</issn><publisher><publisher-name>Shiraz University of Medical Sciences</publisher-name><publisher-loc>Shiraz, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">ijms-39-522</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>
Healing Effect of <italic>Pistacia</italic><italic> Atlantica</italic> Fruit Oil Extract in Acetic Acid-Induced Colitis in Rats
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tanideh</surname><given-names>Nader</given-names></name><degrees>DVM, MPH, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Masoumi</surname><given-names>Samira</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hosseinzadeh</surname><given-names>Massood</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Safarpour</surname><given-names>Ali Reza</given-names></name><degrees>MD, MPH, PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Erjaee</surname><given-names>Hoda</given-names></name><degrees>DVM</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Koohi-Hosseinabadi</surname><given-names>Omid</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Rahimikazerooni</surname><given-names>Salar</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Shiraz Burn Research Center, Colorectal Research Center, Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran;
</aff><aff id="aff2"><label>2</label>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran;
</aff><aff id="aff3"><label>3</label>Colorectal Research Center, Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran;
</aff><aff id="aff4"><label>4</label>Student Research Committee, Veterinary School, Shiraz University, Shiraz, Iran;
</aff><aff id="aff5"><label>5</label>Center for Comparative and Experimental Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
</aff><author-notes><corresp id="cor">Correspondence: Ali Reza Safarpour; MD, MPH, PhD; Colorectal Research Center; Faghihi Hospital, Zand Street, Shiraz, Iran Tel: +98 71 38320395 Fax: +98 71 32330724 Emails: fsafarpour@yahoo.com asafarpour@sums.ac.ir </corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2014</year></pub-date><volume>39</volume><issue>6</issue><fpage>522</fpage><lpage>528</lpage><history><date date-type="received"><day>24</day><month>11</month><year>2013</year></date><date date-type="rev-recd"><day>3</day><month>2</month><year>2014</year></date><date date-type="accepted"><day>2</day><month>3</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014: Iranian Journal of Medical Sciences</copyright-statement><license><license-p>
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
</license-p></license></permissions><abstract><p>
<bold>Background:</bold> Considering the anti-oxidant properties of <italic>Pistacia</italic><italic> atlantica </italic>and lack of data regarding its efficacy in the treatment of ulcerative colitis, this study aims at investigating the effect of the <italic>Pistacia</italic><italic> atlantica</italic> fruit extract in treating experimentally induced colitis in a rat model.
</p><p>
<bold>Methods:</bold> Seventy male Sprague-Dawley rats (weighing 220&#x000b1;20 g) were used. All rats fasted 24 hours before the experimental procedure. The rats were randomly divided into 7 groups, each containing 10 induced colitis with 2ml acetic acid (3%). Group 1 (Asacol), group 2 (base gel) and group 7 (without treatment) were assigned as control groups. Group 3 (300 mg/ml) and group 4 (600 mg/ml) received <italic>Pistacia</italic><italic> atlantica</italic> fruit orally. Group 5 (10% gel) and group 6 (20% gel) received <italic>Pistacia</italic><italic> atlantica</italic> in the form of gel as enema. Macroscopic, histopathological examination and MDA measurement were carried out.
</p><p>
<bold>Results:</bold> All groups revealed significant macroscopic healing in comparison with group 7 (P&#x0003c;0.001). Regarding microscopic findings in the treatment groups compared with group 7, the latter group differed significantly with groups 1, 2, 4 and 6 (P&#x0003c;0.001). There was a significant statistical difference in MDA scores of the seven treatment groups (F(5,54)=76.61, P&#x0003c;0.001). Post-hoc comparisons indicated that the mean&#x000b1;SD score of Asacol treated group (1.57&#x000b1;0.045) was not significantly different from groups 4 (1.62&#x000b1;0.024) and 6 <italic>(</italic>1.58&#x000b1;0.028).
</p><p>
<bold>Conclusion: </bold>Our study showed that a high dose of <italic>Pistacia</italic><italic> atlantica</italic> fruit oil extract, administered orally and rectally can improve colitis physiologically and pathologically in a rat model, and may be efficient for ulcerative colitis.
</p></abstract><kwd-group><title>Keywords</title><kwd>Enema</kwd><kwd>Colitis</kwd><kwd>Rat</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>
Inflammatory bowel disease (IBD) is characterized by chronic, relapsing, idiopathic inflammation of the gastrointestinal tract. The two major forms of IBD are ulcerative colitis and Crohn&#x02019;s disease.<sup><xref rid="B1" ref-type="bibr">1</xref></sup> These two forms of IBD are considered to be more frequent in northern Europe and North America. Although a lower prevalence has been reported in Asia (due to the traditional diet containing a variety of flavonoids which might be a protective factor for colon disease), IBD is on a rising trend.<sup><xref rid="B1" ref-type="bibr">1</xref></sup><sup>-</sup><sup><xref rid="B3" ref-type="bibr">3</xref></sup> The exact cause of the disease is unknown, however few possible factors could be genetic, immunologic, environmental and oxidative stress.<sup><xref rid="B2" ref-type="bibr">2</xref></sup><sup>,</sup><sup><xref rid="B3" ref-type="bibr">3</xref></sup> Additionally, evidence reveals that reactive oxygen species (ROS) and initiation of lipid peroxidation which are produced in inflamed mucosa, play an important role in the pathogenesis of colitis.<sup><xref rid="B4" ref-type="bibr">4</xref></sup> Oxidative stress causes production of free radicals that elevate inflammatory mediators and damage intestinal mucosa.<sup><xref rid="B4" ref-type="bibr">4</xref></sup><sup>,</sup><sup><xref rid="B5" ref-type="bibr">5</xref></sup> IBD patients also have low quality of life and risk factor for colon cancer.<sup><xref rid="B6" ref-type="bibr">6</xref></sup>
</p><p>
Anti-inflammatory agents such as glucocorticoids and salicylates as well as biological agents against tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) are common treatments for ulcerative colitis.<sup><xref rid="B5" ref-type="bibr">5</xref></sup> These drugs have various side effects; therefore, there is a rising trend in the world to use herbal drugs for treating ulcerative colitis.<sup><xref rid="B7" ref-type="bibr">7</xref></sup> Herbal medicines are widely used in traditional methods of curing diseases among native people. Moreover, in recent years the therapeutic effects of some herbal drugs such as antioxidants are proven in clinical settings.<sup><xref rid="B4" ref-type="bibr">4</xref></sup>
</p><p>
<italic>Pistacia</italic><italic> atlantica</italic> or Bene (from the family Anacardiaceae) is a native fruit in Iran that is used in traditional herbal medicine.<sup><xref rid="B8" ref-type="bibr">8</xref></sup>
<italic>Pistacia</italic><italic> atlantica&#x02019;s</italic> oil, which is called the Bene Hull Oil (BHO) has been recently introduced to the world as a highly stable compound with anti-oxidative properties. The components of BHO include 6.5% unsaponifiable matter (common in vegetable oil), carotenes, tocopherols and alcohols. Tocopherols and tocotrienols have antioxidant activity and act similar to vitamin E which is beneficial for human health.<sup><xref rid="B9" ref-type="bibr">9</xref></sup><sup>,</sup><sup><xref rid="B10" ref-type="bibr">10</xref></sup>
</p><p>
<italic>Pistacia</italic><italic> atlantica</italic> is believed to have several therapeutic properties such as relieving upper abdominal discomfort and pain, dyspepsia and peptic ulcer. Pistacia spp. is a diuretic and stimulant agents.<sup><xref rid="B11" ref-type="bibr">11</xref></sup> Several studies have reported the antimicrobial and analgesic activity of <italic>Pistacia</italic><italic> atlantica.</italic><sup><xref rid="B12" ref-type="bibr">12</xref></sup><sup>-</sup><sup><xref rid="B14" ref-type="bibr">14</xref></sup>
</p><p>
Antioxidant properties of <italic>Pistacia</italic><italic> atlantica</italic> might be an alternative medicine or beneficial food for the prevention or treatment of IBD patients. Considering the lack of data regarding its efficacy in treating ulcerative colitis, this study investigates the effect of the <italic>Pistacia</italic><italic> atlantica</italic> fruit extract in treating experimentally induced colitis in a rat model.
</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><p>
<italic>Gel Preparation</italic>
</p><p>
Gel preparation was done in a pharmacology lab under the supervision of expert technicians. The main substance was carboxymethyl cellulose (CMC). 2% sodium CMC was mixed in 5% glycerol and continuously stirred with a mixer at 500 RPM in order to prepare a gel-forming agent. In the next step, <italic>Pistacia</italic><italic> atlantica</italic> extracts (10%, and 20%) were added to deionized water. The mixtures were gradually added to the Na-CMC with glycerol and finally the prepared gel was homogenized for 30 minutes and all formulations were collected in an aluminum tube in the refrigerator.
</p><p>
<italic>Animals</italic>
</p><p>The present animal study was approved by the Ethics Committee of Shiraz University of Medical Sciences (registration number: 90-3894) and all relevant considerations regarding animal rights were taken into account. This study was carried out at the Laboratory Animal Center of Shiraz University of Medical Sciences, Shiraz, Iran. Seventy male Sprague-Dawley rats weighing 220&#x000b1;20g were used. Animals were housed in standard cages with free access to tap water and standard food (ad libitum) and maintained at a controlled temperature (23&#x000b1;1&#x000ba;C) with a 12/12 hour light-dark cycle. All rats fasted for 24 hours before the experimental procedure. </p><p>
<italic>Extract Preparation</italic>
</p><p>
<italic>Pistacia</italic><italic> atlantica</italic> fresh fruits were prepared from Shiraz (Fars, Southern Iran) and authenticated by Pharmacology Department of Shiraz Medical School. For the preparation of oil extract, dried and finely powdered fruit (100 g) was soaked in an adequate volume of N-hexane (450 cc) and the extraction was continued for 48 hours to obtain the full extract using the percolation method. The extract was then filtered and evaporated in a rotary evaporator under reduced pressure resulting in a semisolid and oily extract. The final product was then prepared in two doses of 300 mg/kg and 600 mg/kg. The gel form was prepared in concentrations of 10% and 20%.
</p><p>
<italic>Experimental Design</italic>
</p><p>Colitis was induced in the rats with 2 ml acetic acid 3% by intracolonic instillation through a polyethylene catheter, which was placed 8 cm from the anus under anesthesia with ketamine (90 mg/kg) and xylazine (5 mg/kg). The rats were randomly divided into 7 groups of ten, as follows:</p><list list-type="bullet"><list-item><p>Groups 1 and 2 were the control groups, respectively receiving 1 ml Asacol (Mesalamine) and 1 ml base gel (carboxymethylcellulose) as enema.</p></list-item><list-item><p>
Groups 3 and 4 received 300 and 600 mg/kg <italic>Pistacia</italic><italic> atlantica</italic> fruit oil extract orally, respectively.
</p></list-item><list-item><p>
Groups 5 and 6 received 10% and 20% gel from <italic>Pistacia</italic><italic> atlantica&#x02019;s</italic> fruit as enema.
</p></list-item><list-item><p>Group 7 was the third control group in which colitis were induced without treatment.</p></list-item></list><p>
All groups were subjected to relevant protocol and after 7 days, rats were sacrificed in a CO<sub>2</sub> chamber. The abdomen was opened and the colon was exposed. The distal 8 cm of the colon was removed and opened by longitudinal incision. The mucosal surface was washed with saline buffer and then the mucosal injury was macroscopically assessed using Morris et al.&#x02019;s<sup><xref rid="B15" ref-type="bibr">15</xref></sup> grading scale (0: no change, 1: mucosal erythema only, 2: mild mucosal edema, slight bleeding or slight erosion, 3: moderate edema, bleeding ulcers or erosions, 4: severe ulceration, erosions, edema and tissue necrosis).
</p><p>
For histological examination, the colon tissue was fixed in 10% formalin sectioned in 5 &#x003bc;m thick sections, and stained with haematoxylin and eosin. All slides were reviewed by a single blinded pathologist and sub-classified according to the &#x0201c;repair scoring system&#x0201d;.<sup><xref rid="B16" ref-type="bibr">16</xref></sup> Inflammation and crypt damage was assessed and the sections were coded using a modified validated scoring scheme as described by Appleyard and Wallace.<sup><xref rid="B17" ref-type="bibr">17</xref></sup>
</p><p>
<italic>Tissue MDA Measurements</italic>
</p><p>
MDA production was measured in tissue samples by the method proposed by Ohkawa et al.<sup><xref rid="B18" ref-type="bibr">18</xref></sup> MDA forms a colored complex in the presence of thiobarbituric acid (TBA) and n-butanol, which is detectable by the measurement of absorbance at 532 nm. Absorbance was measured using a Shimadzu UV-160 spectrophotometer. 1,1&#x000b4;,3,3&#x000b4;-tetramethoxypropane was used as standard and the results were expressed as &#x000b5;mol/g protein.<sup><xref rid="B19" ref-type="bibr">19</xref></sup>
</p><p>
<italic>Statistical Analysis</italic>
</p><p>Statistical analyses were performed using SPSS 21 software (SPSS, Chicago, IL, USA). One way ANOVA, Kruskal-Wallis and Mann-Whitney tests were used. Data were expressed as mean&#x000b1;SD, frequency, and percentages. A P value &#x0003c;0.05 was considered as statistically significant. Moreover, Bonferroni correction was performed as an appropriate form of analysis. </p></sec><sec sec-type="results"><title>Results</title><p>
<italic>Macroscopic Findings</italic>
</p><p>
All specimens were assessed according to the Moris scoring system.<sup><xref rid="B15" ref-type="bibr">15</xref></sup> Kruskal&#x02013;Wallis test revealed significant macroscopic healing between group 7 (colitis induced without treatment) and other groups (P&#x0003c;0.001).
</p><p>To determine the exact difference between the groups, Mann-Whitney U test between pairs of groups was performed. A statistically significant difference was seen between groups 7 and 1 (standard treatment with Asacol) (P&#x0003c;0.001), groups 7 and 4 (extract 600 mg oral) (P=0.002) and groups 7 and 6 (extract 20% gel) (P=0.001). The Bonferroni correction method was applied according to the number of comparisons.</p><p>
<italic>Histopathological</italic>
<italic> Findings</italic>
</p><p>
Microscopic findings included focal crypt disorganization, ulceration, moderate colitis, and crypt disorganization, regeneration, granulation tissue and mild inflammation (<xref ref-type="fig" rid="F1">figure 1</xref>). The samples were classified microscopically based on the repair scoring system.<sup><xref rid="B16" ref-type="bibr">16</xref></sup> With respect to the microscopic findings in the treatment groups compared with group 7 (colitis induced without treatment), as shown in <xref ref-type="table" rid="T1">table 1</xref>, this group differed significantly from groups 1, 4 and 6 (P&#x0003c;0.001). To control for the type 1 error, the Bonferroni correction method was applied to the alpha value.
</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Photos from the pathology slides showing the effects of the Pistacia atlantica. A: Focal crypt disorganization and cryptitis (group 6, H&#x00026;E, &#x000d7;400), B: Ulceration, moderate colitis, and crypt disorganization (groups 5 and 3, H&#x00026;E, &#x000d7;100), C: Regeneration, granulation tissue and mild inflammation (groups 6 and 4, H&#x00026;E, &#x000d7;400</p></caption><graphic xlink:href="ijms-39-522-g001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>
Microscopic and macroscopic feature scores in the seven studied groups to evaluate the effect of <italic>Pistacia</italic><italic> atlantica</italic> in acetic acid-induced colitis in rats
</p></caption><table frame="hsides" rules="all"><thead><tr><th style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Groups</bold>
</th><th style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Macroscopic scores</bold>
<break/>
<bold>(mean</bold>
<bold>&#x000b1;</bold>
<bold>SD)</bold>
</th><th style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1">
<bold>Histopathologic</bold>
<bold> scores</bold>
<break/>
<bold>(mean</bold>
<bold>&#x000b1;</bold>
<bold>SD)</bold>
</th></tr></thead><tbody><tr><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> Control (Asacol) </td><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 1&#x000b1;0 </td><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 1&#x000b1;0 </td></tr><tr><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> Colitis (non-treated) </td><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 3.88&#x000b1;0.75 </td><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 3&#x000b1;1.67 </td></tr><tr><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> Base of gel </td><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 2.10&#x000b1;0.91 </td><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 2&#x000b1;1.40 </td></tr><tr><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> Enema 20% gel </td><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 1.20&#x000b1;1.03 </td><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 1.20&#x000b1;1.07 </td></tr><tr><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> Enema 10% gel </td><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 1.50&#x000b1;0.97 </td><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 1.60&#x000b1;1.42 </td></tr><tr><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> Oral 300 mg </td><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 2.60&#x000b1;1.14 </td><td style=" color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 2.80&#x000b1;1.87 </td></tr><tr><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> Oral 600 mg </td><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 1.37&#x000b1;1.30 </td><td style="background-color:#F0F0FA; color:#000000;" align="left" valign="middle" rowspan="1" colspan="1"> 0.87&#x000b1;1.12 </td></tr></tbody></table><table-wrap-foot><p>
<italic>&#x000a0;</italic>
</p></table-wrap-foot></table-wrap><p>
<italic>MDA Test Comparison</italic>
</p><p>
A one-way between-group analysis of variance was used to analyze the impact of the new treatment on inflammation levels, as measured by the MDA test. There was a statistically significant difference in MDA scores of the seven groups (F (5,54)=76.61, P&#x0003c;0.001). Post-hoc comparisons using the LSD test indicated that the mean&#x000b1;SD score for group 1 (1.57&#x000b1;0.045) was not significantly different from groups 4 (1.62&#x000b1;0.024) and 6 (1.58&#x000b1;0.028) as shown in <xref ref-type="fig" rid="F2">figure 2</xref>. This result means probable same anti-inflammatory effects of both high doses of the extract (600 mg orally and 20% gel) in comparison with Asacol.
</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Comparison of mean concentration of MDA in seven study groups (nmol/g) to evaluate the effect of Pistacia atlantica in acetic acid-induced colitis in rats.</p></caption><graphic xlink:href="ijms-39-522-g002"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>
In this study, the effect of the <italic>Pistacia</italic><italic> atlantica</italic> fruit extract as well as its effect on reducing inflammation and contribution to tissue repair was examined in acetic acid induced colitis in a rat model. Intrarectal acetic acid injection is an easy, repeatable, and cost-effective method for experimental colitis on small laboratory animals. It is comparable with inflammation and ulcers in the epithelium of the colon, and findings such as damaging the crypts of the intestine and killing epithelial cells and lowering goblet cells. These changes are similar to ulcerative colitis.<sup><xref rid="B19" ref-type="bibr">19</xref></sup>
</p><p>
The findings of this investigation demonstrated that <italic>Pistacia</italic><italic> atlantica</italic> fruit oil extract reduces colonic injury by suppressing oxidative damage. The pathogenesis of the disease was assessed by evaluating different parameters such as macroscopic score, microscopic score and oxidative stress markers like MDA level. We found an improvement and lower MDA levels in the groups treated with the high dose of fruit extract compared with the untreated group. Histological and macroscopic data confirmed that both oral and rectal administration of <italic>Pistacia</italic><italic> atlantica</italic> fruit oil extract could alleviate bowel inflammation. Asacole was used as the standard drug, which produced no significant difference in the above parameters in comparison with <italic>Pistacia</italic><italic> atlantica</italic> at doses 600 mg/kg (orally) and 20% gel form (rectally).
</p><p>
The fruits of <italic>Pistacia</italic><italic> atlantica</italic> were found to be rich in proteins, oils, fibers, and unsaturated fatty acids, suggesting that they may be valuable as food. The major components of <italic>Pistacia</italic><italic> atlantica</italic> are &#x003b1;-tocopherols and important sterols that have antioxidant properties and health benefits such as being precursors of vitamin D and lowering blood cholesterol.<sup><xref rid="B20" ref-type="bibr">20</xref></sup> Their antioxidant activity is attributed to the presence of tocopherols and tocotrienols, and are as active as vitamin E.<sup><xref rid="B1" ref-type="bibr">1</xref></sup><sup>,</sup><sup><xref rid="B2" ref-type="bibr">2</xref></sup> Shimizu et al.,<sup><xref rid="B21" ref-type="bibr">21</xref></sup> showed that a vitamin E enriched diet could be beneficial in the treatment of ulcerative colitis in rats. The therapeutic role of <italic>Pistacia</italic><italic> atlantica</italic> for ulcerative colitis in rats may be similar to vitamin E, which is consistent with findings by Shimizu et al.<sup><xref rid="B21" ref-type="bibr">21</xref></sup>
</p><p>
Ademoglu et al.<sup><xref rid="B22" ref-type="bibr">22</xref></sup> found that vitamin E and selenium supplementation, significantly reduced both the severity of colonic lesions and the levels of MDA and protein carbonyl. The researchers offered antioxidants and some micronutrients as therapeutic agents. In another study, vitamin E levels were also found to be low in some patients with IBD and low levels of vitamin E was found during active disease.<sup><xref rid="B23" ref-type="bibr">23</xref></sup>
</p><p>
Vitamin E has beneficial effects intraluminally. It is a lipid soluble radical scavenger and a lipid peroxidation suppressor, which reduces the free radical generating capacity of the feces in ulcerative colitis.<sup><xref rid="B24" ref-type="bibr">24</xref></sup><sup>,</sup><sup><xref rid="B25" ref-type="bibr">25</xref></sup> Vitamin E can also reduce intestinal inflammation by preventing the activation of the transcription factor NF-&#x003ba;B, which plays an important role in intestinal inflammation.<sup><xref rid="B26" ref-type="bibr">26</xref></sup><sup>,</sup><sup><xref rid="B27" ref-type="bibr">27</xref></sup> This likelihood is supported by several in vitro studies in which vitamin E inhibited tumor necrosis factor-&#x003b1;-induced NF-&#x003ba;B activation in human Jurkat T-cells<sup><xref rid="B28" ref-type="bibr">28</xref></sup> and inhibited the activation and translocation of NF-&#x003ba;B to the nucleus and the binding of the activated proteins to the &#x003ba;B DNA site.<sup><xref rid="B29" ref-type="bibr">29</xref></sup>
</p><p>
Dost et al.<sup><xref rid="B4" ref-type="bibr">4</xref></sup> found that <italic>Hypericum</italic><italic> perforatum</italic> is effective in decreasing MDA levels in TNBS-induced colitis in rats due to its antioxidant activity. Consistently, in our study, MDA levels decreased in the treatment groups and this reduction may be attributed to the protective effect of <italic>Pistacia</italic><italic> atlantica</italic> against lipid peroxidation, which may in turn be due to the presence of tochpherols and tocotrienols.
</p><p>
In another study, CMC-treated mice had significantly lower histology scores and lower colon weight/length ratios, indicating that CMC-treatment alone may play a role in reducing colonic injury.<sup><xref rid="B30" ref-type="bibr">30</xref></sup> CMC appears to be beneficial despite high levels of pro-inflammatory cytokines, suggesting a mechanism of action independent of an imbalance in cytokine production. Possible mechanisms could include an increase in cellulose derived nutrients to promote mucosal healing or immune function as well as variations in the intestinal flora. Thus, CMC may have exerted its positive effects on the intestinal lumen by increasing the viscosity of the mucous layer, thereby altering patterns of pathogenic bacteria migration through the mucous layer, where they would have otherwise led to inflammation and damage to the intestine.<sup><xref rid="B29" ref-type="bibr">29</xref></sup>
</p><p>
Common belief indicates that herbal therapies are safer and less toxic than conventional treatment in patients with IBD. Herbal medicines such as Curcumin, Aloe Vera, and <italic>Boswellia</italic><italic> Serrata</italic> are effective in ulcerative colitis based on their antioxidant properties, which is similar to that of <italic>Pestacia</italic><italic> atlantica.</italic><sup><xref rid="B31" ref-type="bibr">31</xref></sup> However, not all studies have shown consistent and promising results with respect to the role of herbal therapy in IBD. The reasons for such controversial findings could be related to different study designs, small sample size, lack of adequate control, and the variation in drug formulations and doses.<sup><xref rid="B31" ref-type="bibr">31</xref></sup> All these confounding factors were considered in this study.
</p><p>
Most of the herbal therapies used for IBD have been associated with minimal adverse effects compared with glycocorticosteroids. According to previous studies, <italic>Pistacia</italic><italic> atlantica</italic>, also has no proven hepatotoxicity effects.<sup><xref rid="B32" ref-type="bibr">32</xref></sup><sup>,</sup><sup><xref rid="B33" ref-type="bibr">33</xref></sup> This treatment will be attractive to many patients and cost effective in comparison with glycocorticoid therapy. No toxic effect of <italic>Pistacia</italic><italic> atlantica</italic> has been reported, showing that higher doses of this extract may be effective and safe. Recently, resistance to drugs, their toxicity and side effects have been reported; therefore, there is a great need for the development of an effective, safe and topical herbal drugs such as a <italic>Pistacia</italic><italic> atlantica</italic> extract for different forms of ulcerative colitis.
</p><p>
This study had limitations such as the lack of evaluation of anti-inflammatory markers and stereology of colon tissue. Certainly, further studies are required to clarify the mechanisms by which <italic>Pistacia</italic><italic> atlantica</italic> exerts its beneficial effects and its efficacy should be confirmed through clinical trials. This study opens a path for future clinical trials in humans.
</p></sec><sec sec-type="conclusion"><title>Conclusion</title><p>
<italic>Pistacia</italic><italic> atlantica</italic> fruit extract orally and rectally can improve induced colitis physiologically and pathologically in a rat model. This therapy is potentially safe, cost-effective, and efficient for treating ulcerative colitis. Further investigations of its clinical application in human model are warranted.
</p></sec></body><back><ack><title>Acknowledgment</title><p>We would like to express our special gratitude and thanks to Vice Chancellor of Research of Shiraz University of Medical Sciences for their financial supports.</p><p>
This research is part of the requirement for obtaining a medical degree of Samira Masoumi (Ethics Committee Code: 3894).
</p></ack><sec><title/><p>
<bold>Conflict of Interest:</bold> None declared.
</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahimi</surname><given-names>R</given-names></name><name><surname>Mozaffari</surname><given-names>S</given-names></name><name><surname>Abdollahi</surname><given-names>M</given-names></name></person-group><article-title>On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies</article-title><source> Dig Dis Sci</source><year>2009</year><volume>54</volume><fpage>471</fpage><lpage>80</lpage><comment>doi: 10.1007/s10620-008-0368-x. PubMed PMID: 18618255</comment><?supplied-pmid 18618255?><pub-id pub-id-type="pmid">18618255</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>SK</given-names></name><name><surname>Loftus</surname><given-names>EV Jr</given-names></name><name><surname>Sandborn</surname><given-names>WJ</given-names></name></person-group><article-title>Epidemiology of inflammatory bowel disease in Asia</article-title><source> Inflamm Bowel Dis</source><year>2001</year><volume>7</volume><fpage>260</fpage><lpage>70</lpage><comment>doi: 10.1097/00054725-200108000-00013. PubMed PMID: 11515854</comment><?supplied-pmid 11515854?><pub-id pub-id-type="pmid">11515854</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safarpour</surname><given-names>AR</given-names></name><name><surname>Hosseini</surname><given-names>SV</given-names></name><name><surname>Mehrabani</surname><given-names>D</given-names></name></person-group><article-title>Epidemiology of inflammatory bowel diseases in iran and Asia; a mini review</article-title><source> Iran J Med Sci</source><year>2013</year><volume>38</volume><fpage>140</fpage><lpage>9</lpage><comment>PubMed PMID: 24031103; PubMed Central PMCID: PMC3771215</comment><?supplied-pmid 24031103?><pub-id pub-id-type="pmid">24031103</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dost</surname><given-names>T</given-names></name><name><surname>Ozkayran</surname><given-names>H</given-names></name><name><surname>Gokalp</surname><given-names>F</given-names></name><name><surname>Yenisey</surname><given-names>C</given-names></name><name><surname>Birincioglu</surname><given-names>M</given-names></name></person-group><article-title>The effect of Hypericum perforatum (St. John&#x02019;s Wort) on experimental colitis in rat</article-title><source> Dig Dis Sci</source><year>2009</year><volume>54</volume><fpage>1214</fpage><lpage>21</lpage><comment>doi: 10.1007/s10620-008-0477-6. PubMed PMID: 18754092</comment><?supplied-pmid 18754092?><pub-id pub-id-type="pmid">18754092</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehrabani</surname><given-names>D</given-names></name><name><surname>Ziaei</surname><given-names>M</given-names></name><name><surname>Hosseini</surname><given-names>SV</given-names></name><name><surname>Ghahramani</surname><given-names>L</given-names></name><name><surname>Bananzadeh</surname><given-names>AM</given-names></name><name><surname>Ashraf</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>The effect of calendula officinalis in therapy of acetic Acid induced ulcerative colitis in dog as an animal model</article-title><source> Iran Red Crescent Med J</source><year>2011</year><volume>13</volume><fpage>884</fpage><lpage>90</lpage><comment>PubMed PMID: 22737434; PubMed Central PMCID: PMC3371898</comment><?supplied-pmid 22737434?><pub-id pub-id-type="pmid">22737434</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarur</surname><given-names>AJ</given-names></name><name><surname>Strobel</surname><given-names>SG</given-names></name><name><surname>Deshpande</surname><given-names>AR</given-names></name><name><surname>Abreu</surname><given-names>MT</given-names></name></person-group><article-title>Predictors of Aggressive Inflammatory Bowel Disease</article-title><source> Gastroenterol Hepatol</source><year>2011</year><volume>7</volume><fpage>652</fpage><lpage>659</lpage><comment>PubMed PMID: 22298958; PubMed Central PMCID: PMC3265007</comment><?supplied-pmid 22298958?><pub-id pub-id-type="pmid">22298958</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>CT</given-names></name><name><surname>Meng</surname><given-names>SY</given-names></name><name><surname>Pan</surname><given-names>BR</given-names></name></person-group><article-title>Drug therapy for ulcerative colitis</article-title><source> World J Gastroenterol</source><year>2004</year><volume>10</volume><fpage>2311</fpage><lpage>7</lpage><comment>PubMed PMID: 15285010</comment><?supplied-pmid 15285010?><pub-id pub-id-type="pmid">15285010</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farhoosh</surname><given-names>R</given-names></name><name><surname>Haddad Khodaparast</surname><given-names>MH</given-names></name><name><surname>Sharif</surname><given-names>A</given-names></name></person-group><article-title>Bene hull oil as a highly stable and antioxidative vegetable oil</article-title><source> Eur J Lipid Sci Technol</source><year>2009</year><volume>111</volume><fpage>1259</fpage><lpage>65</lpage><comment>doi: 10.1002/ejlt.200900081</comment></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farhoosh</surname><given-names>R</given-names></name><name><surname>Tavassoli-Kafrani</surname><given-names>MH</given-names></name><name><surname>Sharif</surname><given-names>A</given-names></name></person-group><article-title>Antioxidant activity of the fractions separated from the unsaponifiable matter of bene hull oil</article-title><source> Food Chem</source><year>2011</year><volume>126</volume><fpage>583</fpage><lpage>9</lpage><comment>doi: 10.1016/j.foodchem.2010.11.047</comment></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delazar</surname><given-names>A</given-names></name><name><surname>Reid</surname><given-names>RG</given-names></name><name><surname>Sarker</surname><given-names>SD</given-names></name></person-group><article-title>
GC-MS analysis of the essential oil from the oleoresin of <italic>Pistacia</italic><italic> atlantica</italic> var. mutica</article-title><source> Chem Nat Compd</source><year>2004</year><volume>40</volume><fpage>24</fpage><lpage>7</lpage><comment>doi: 10.1023/B:CONC.0000025459.72590.9e</comment></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghalem</surname><given-names>BR</given-names></name><name><surname>Mohamed</surname><given-names>B</given-names></name></person-group><article-title>Bactericidal activity of Pistacia atlantica. Desf mastic gum against certain pathogens</article-title><source> Afr J Plant Sci</source><year>2009</year><volume>3</volume><fpage>13</fpage><lpage>5</lpage></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghalem</surname><given-names>BR</given-names></name><name><surname>Mohamed</surname><given-names>B</given-names></name></person-group><article-title>Essential oil from gum of <italic>Pistacia</italic><italic> atlantica </italic>Desf.: Screening of antimicrobial activity</article-title><source> Afr J Pharm Pharacol</source><year>2009</year><volume>3</volume><fpage>87</fpage><lpage>91</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>NS</given-names></name><name><surname>Waheed</surname><given-names>A</given-names></name><name><surname>Farman</surname><given-names>M</given-names></name><name><surname>Qayyum</surname><given-names>A</given-names></name></person-group><article-title>Analgesic and anti-inflammatory effects of Pistacia integerrima extracts in mice</article-title><source> J Ethnopharmacol</source><year>2010</year><volume>129</volume><fpage>250</fpage><lpage>3</lpage><comment>doi: 10.1016/j.jep.2010.03.017. PubMed PMID: 20359528</comment><?supplied-pmid 20359528?><pub-id pub-id-type="pmid">20359528</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhouma</surname><given-names>A</given-names></name><name><surname>Ben Daoud</surname><given-names>H</given-names></name><name><surname>Ghanmi</surname><given-names>S</given-names></name><name><surname>Ben Salah</surname><given-names>H</given-names></name><name><surname>Romdhane</surname><given-names>M</given-names></name><name><surname>Demak</surname><given-names>M</given-names></name></person-group><article-title>Antimicrobial activities of leaf extracts of <italic>Pistacia</italic> and <italic>Schinus</italic> species against some ploant pathogenic fungi and bacteria</article-title><source> J Plant Pathol</source><year>2009</year><volume>91</volume><fpage>339</fpage><lpage>45</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>GP</given-names></name><name><surname>Beck</surname><given-names>PL</given-names></name><name><surname>Herridge</surname><given-names>MS</given-names></name><name><surname>Depew</surname><given-names>WT</given-names></name><name><surname>Szewczuk</surname><given-names>MR</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name></person-group><article-title>Hapten-induced model of chronic inflammation and ulceration in the rat colon</article-title><source> Gastroenterology</source><year>1989</year><volume>96</volume><fpage>795</fpage><lpage>803</lpage><comment>PubMed PMID: 2914642</comment><?supplied-pmid 2914642?><pub-id pub-id-type="pmid">2914642</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramov</surname><given-names>Y</given-names></name><name><surname>Golden</surname><given-names>B</given-names></name><name><surname>Sullivan</surname><given-names>M</given-names></name><name><surname>Botros</surname><given-names>SM</given-names></name><name><surname>Miller</surname><given-names>JJ</given-names></name><name><surname>Alshahrour</surname><given-names>A</given-names></name><etal/></person-group><article-title>Histologic characterization of vaginal vs. abdominal surgical wound healing in a rabbit model</article-title><source> Wound Repair Regen</source><year>2007</year><volume>15</volume><fpage>80</fpage><lpage>6</lpage><comment>doi: 10.1111/j.1524-475x.2006.00188.x. PubMed PMID: 17244323</comment><?supplied-pmid 17244323?><pub-id pub-id-type="pmid">17244323</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appleyard</surname><given-names>CB</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name></person-group><article-title>Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs</article-title><source> Am J Physiol</source><year>1995</year><volume>269</volume><fpage>119</fpage><lpage>25</lpage><comment>PubMed PMID: 7631788</comment><?supplied-pmid 7631788?><pub-id pub-id-type="pmid">7631788</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohkawa</surname><given-names>H</given-names></name><name><surname>Ohishi</surname><given-names>N</given-names></name><name><surname>Yagi</surname><given-names>K</given-names></name></person-group><article-title>Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction</article-title><source> Anal Biochem</source><year>1979</year><volume>95</volume><fpage>351</fpage><lpage>8</lpage><comment>doi: 10.1016/0003-2697(79)90738-3. PubMed PMID: 36810</comment><?supplied-pmid 36810?><pub-id pub-id-type="pmid">36810</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurjus</surname><given-names>AR</given-names></name><name><surname>Khoury</surname><given-names>NN</given-names></name><name><surname>Reimund</surname><given-names>JM</given-names></name></person-group><article-title>Animal models of inflammatory bowel disease</article-title><source> J Pharmacol Toxicol Methods</source><year>2004</year><volume>50</volume><fpage>81</fpage><lpage>92</lpage><comment>doi: 10.1016/j.vascn.2003.12.002. PubMed PMID: 15385082</comment><?supplied-pmid 15385082?><pub-id pub-id-type="pmid">15385082</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benhassaini</surname><given-names>H</given-names></name><name><surname>Bendahmane</surname><given-names>M</given-names></name><name><surname>Benchalgo</surname><given-names>N</given-names></name></person-group><article-title>The chemical composition of fruits of Pistacia atlantica desf. subsp. atlantica from Algeria</article-title><source> Chem Nat Compd</source><year>2007</year><volume>43</volume><fpage>121</fpage><lpage>4</lpage><comment>doi: 10.1007/s10600-007-0059-4</comment></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>J</given-names></name><name><surname>Ohtuka</surname><given-names>Y</given-names></name><name><surname>Oguchi</surname><given-names>S</given-names></name><name><surname>Kaneko</surname><given-names>K</given-names></name><name><surname>Yamashiro</surname><given-names>Y</given-names></name></person-group><article-title>Effects of n-3 polyunsaturated fatty acids and vitamin E on colonic mucosal leukotriene generation, lipid peroxidation, and microcirculation in rats with experimental colitis</article-title><source> Digestion</source><year>2001</year><volume>63</volume><fpage>49</fpage><lpage>54</lpage><comment>doi: 10.1159/000051872. PubMed PMID: 11173900</comment><?supplied-pmid 11173900?><pub-id pub-id-type="pmid">11173900</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ademoglu</surname><given-names>E</given-names></name><name><surname>Erbil</surname><given-names>Y</given-names></name><name><surname>Tam</surname><given-names>B</given-names></name><name><surname>Barbaros</surname><given-names>U</given-names></name><name><surname>Ilhan</surname><given-names>E</given-names></name><name><surname>Olgac</surname><given-names>V</given-names></name><etal/></person-group><article-title>Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis</article-title><source> Dig Dis Sci</source><year>2004</year><volume>49</volume><fpage>102</fpage><lpage>8</lpage><comment>doi: 10.1023/b:ddas.0000011610.47179.0b. PubMed PMID: 14992443</comment><?supplied-pmid 14992443?><pub-id pub-id-type="pmid">14992443</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Odorico</surname><given-names>A</given-names></name><name><surname>Bortolan</surname><given-names>S</given-names></name><name><surname>Cardin</surname><given-names>R</given-names></name><name><surname>D&#x02019;Inca&#x02019;</surname><given-names>R</given-names></name><name><surname>Martines</surname><given-names>D</given-names></name><name><surname>Ferronato</surname><given-names>A</given-names></name><etal/></person-group><article-title>Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease</article-title><source> Scand J Gastroenterol</source><year>2001</year><volume>36</volume><fpage>1289</fpage><lpage>94</lpage><comment>doi: 10.1080/003655201317097146. PubMed PMID: 11761019</comment><?supplied-pmid 11761019?><pub-id pub-id-type="pmid">11761019</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreadou</surname><given-names>I</given-names></name><name><surname>Papalois</surname><given-names>A</given-names></name><name><surname>Triantafillidis</surname><given-names>J</given-names></name><name><surname>Demonakou</surname><given-names>M</given-names></name><name><surname>Govosdis</surname><given-names>V</given-names></name><name><surname>Vidali</surname><given-names>M</given-names></name><etal/></person-group><article-title>Beneficial effect of a novel nonsteroidal anti-inflammatory agent with basic character and antioxidant properties on experimental colitis in rats</article-title><source> Annals of Gastroenterology</source><year>2001</year><volume>14</volume><fpage>293</fpage><lpage>8</lpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niki</surname><given-names>E</given-names></name></person-group><article-title>Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence</article-title><source> Free Radic Biol Med</source><year>2014</year><volume>66</volume><fpage>3</fpage><lpage>12</lpage><comment>doi: 10.1016/j.freeradbiomed.2013.03.022. PubMed PMID: 23557727</comment><?supplied-pmid 23557727?><pub-id pub-id-type="pmid">23557727</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calfee-Mason</surname><given-names>KG</given-names></name><name><surname>Spear</surname><given-names>BT</given-names></name><name><surname>Glauert</surname><given-names>HP</given-names></name></person-group><article-title>Vitamin E inhibits hepatic NF-kappaB activation in rats administered the hepatic tumor promoter, phenobarbital</article-title><source> J Nutr</source><year>2002</year><volume>132</volume><fpage>3178</fpage><lpage>85</lpage><comment>PubMed PMID: 12368415</comment><?supplied-pmid 12368415?><pub-id pub-id-type="pmid">12368415</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schottelius</surname><given-names>AJ</given-names></name><name><surname>Dinter</surname><given-names>H</given-names></name></person-group><article-title>Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer</article-title><source> Cancer Treat Res</source><year>2006</year><volume>130</volume><fpage>67</fpage><lpage>87</lpage><comment>doi: 10.1007/0-387-26283-0_3. PubMed PMID: 16610703</comment><?supplied-pmid 16610703?><pub-id pub-id-type="pmid">16610703</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalaf</surname><given-names>H</given-names></name><name><surname>Jass</surname><given-names>J</given-names></name><name><surname>Olsson</surname><given-names>PE</given-names></name></person-group><article-title>Differential cytokine regulation by NF-&#x003ba;B and AP-1 in Jurkat T-cells</article-title><source> BMC Immunol</source><year>2010</year><volume>11</volume><fpage>26</fpage><pub-id pub-id-type="pmid">20507572</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swidsinski</surname><given-names>A</given-names></name><name><surname>Sydora</surname><given-names>BC</given-names></name><name><surname>Doerffel</surname><given-names>Y</given-names></name><name><surname>Loening-Baucke</surname><given-names>V</given-names></name><name><surname>Vaneechoutte</surname><given-names>M</given-names></name><name><surname>Lupicki</surname><given-names>M</given-names></name><etal/></person-group><article-title>Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota</article-title><source> Inflamm Bowel Dis</source><year>2007</year><volume>13</volume><fpage>963</fpage><lpage>70</lpage><comment>doi: 10.1002/ibd.20163. PubMed PMID: 17455202</comment><?supplied-pmid 17455202?><pub-id pub-id-type="pmid">17455202</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ung</surname><given-names>VY</given-names></name><name><surname>Foshaug</surname><given-names>RR</given-names></name><name><surname>MacFarlane</surname><given-names>SM</given-names></name><name><surname>Churchill</surname><given-names>TA</given-names></name><name><surname>Doyle</surname><given-names>JS</given-names></name><name><surname>Sydora</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti-inflammatory effect in the IL-10 gene-deficient mouse model of IBD</article-title><source> Dig Dis Sci</source><year>2010</year><volume>55</volume><fpage>1272</fpage><lpage>7</lpage><comment>doi: 10.1007/s10620-009-0843-z. PubMed PMID: 19513843</comment><?supplied-pmid 19513843?><pub-id pub-id-type="pmid">19513843</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>SC</given-names></name><name><surname>Lam</surname><given-names>YT</given-names></name><name><surname>Tsoi</surname><given-names>KK</given-names></name><name><surname>Chan</surname><given-names>FK</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name><name><surname>Wu</surname><given-names>JC</given-names></name></person-group><article-title>Systematic review: the efficacy of herbal therapy in inflammatory bowel disease</article-title><source> Aliment Pharmacol Ther</source><year>2013</year><volume>38</volume><fpage>854</fpage><lpage>63</lpage><comment>doi: 10.1111/apt.12464. PubMed PMID: 23981095</comment><?supplied-pmid 23981095?><pub-id pub-id-type="pmid">23981095</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>NS</given-names></name><name><surname>Waheed</surname><given-names>A</given-names></name><name><surname>Farman</surname><given-names>M</given-names></name><name><surname>Qayyum</surname><given-names>A</given-names></name></person-group><article-title>Analgesic and anti-inflammatory effects of Pistacia integerrima extracts in mice</article-title><source> J Ethnopharmacol</source><year>2010</year><volume>129</volume><fpage>250</fpage><lpage>3</lpage><comment>doi: 10.1016/j.jep.2010.03.017. PubMed PMID: 20359528</comment><?supplied-pmid 20359528?><pub-id pub-id-type="pmid">20359528</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozorgi</surname><given-names>M</given-names></name><name><surname>Memariani</surname><given-names>Z</given-names></name><name><surname>Mobli</surname><given-names>M</given-names></name><name><surname>Salehi Surmaghi</surname><given-names>MH</given-names></name><name><surname>Shams-Ardekani</surname><given-names>MR</given-names></name><name><surname>Rahimi</surname><given-names>R</given-names></name></person-group><article-title>Five Pistacia species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): A Review of Their Traditional Uses, Phytochemistry, and Pharmacology</article-title><source> The Scientific World Journal</source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>33</lpage><comment>doi: 10.1155/2013/219815</comment></element-citation></ref></ref-list></back></article>
